The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation
Open accessAbstract
N 6-Methyladenosine (m6A) is the most abundant RNA modification in mammal mRNAs and increasing evidence suggests the key roles of m6A in human tumorigenesis. However, whether m6A, especially its ‘reader’ YTHDF1, targets a gene involving in protein translation and thus affects overall protein production in cancer cells is largely unexplored. Here, using multi-omics analysis for ovarian cancer, we identified a novel mechanism involving EIF3C, a subunit of the protein translation initiation factor EIF3, as the direct target of the YTHDF1. YTHDF1 augments the translation of EIF3C in an m6A-dependent manner by binding to m6A-modified EIF3C mRNA and concomitantly promotes the overall translational output, thereby facilitating tumorigenesis and metastasis of ovarian cancer. YTHDF1 is frequently amplified in ovarian cancer and up-regulation of YTHDF1 is associated with the adverse prognosis of ovarian cancer patients. Furthermore, the protein but not the RNA abundance of EIF3C is increased in ovarian cancer and positively correlates with the protein expression of YTHDF1 in ovarian cancer patients, suggesting modification of EIF3C mRNA is more relevant to its role in cancer. Collectively, we identify the novel YTHDF1-EIF3C axis critical for ovarian cancer progression which can serve as a target to develop therapeutics for cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lin, X., Chai, G., Wu, Y., Li, J., Chen, F., Liu, J., Luo, G., Tauler, J., Du, J., Lin, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09865-9 · Cited by 510
RetractedThe cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
Dominissini, D., Moshitch-Moshkovitz, S., Schwartz, S., Salmon-Divon, M., Ungar, L., Osenberg, S., Cesarkas, K., Jacob-Hirsch, J., Amariglio, N., Kupiec, M., et al. (2012) · Nature · doi:10.1038/nature11112 · Cited by 4,884
N6-methyladenosine-dependent regulation of messenger RNA stability
Wang, X., Lu, Z., Gomez, A., Hon, G. C., Yue, Y., Han, D., Fu, Y., Parisien, M., Dai, Q., Jia, G., et al. (2014) · Nature · doi:10.1038/nature12730 · Cited by 4,558
N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
Jia, G., Fu, Y., Zhao, X., Dai, Q., Zheng, G., Yang, Y., Yi, C., Lindahl, T., Pan, T., Yang, Y.-G., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.687 · Cited by 4,106
ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility
Zheng, G., Dahl, J. A., Niu, Y., Fedorcsak, P., Huang, C.-M., Li, C. J., Vågbø, C. B., Shi, Y., Wang, W.-L., Song, S.-H., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.015 · Cited by 3,550
N6-methyladenosine Modulates Messenger RNA Translation Efficiency
Wang, X., Zhao, B. S., Roundtree, I. A., Lu, Z., Han, D., Ma, H., Weng, X., Chen, K., Shi, H., & He, C. (2015) · Cell · doi:10.1016/j.cell.2015.05.014 · Cited by 3,483
A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation
Liu, J., Yue, Y., Han, D., Wang, X., Fu, Y., Zhang, L., Jia, G., Yu, M., Lu, Z., Deng, X., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1432 · Cited by 3,433
Dynamic RNA Modifications in Gene Expression Regulation
Roundtree, I. A., Evans, M. E., Pan, T., & He, C. (2017) · Cell · doi:10.1016/j.cell.2017.05.045 · Cited by 3,399
YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA
Shi, H., Wang, X., Lu, Z., Zhao, B. S., Ma, H., Hsu, P. J., Liu, C., & He, C. (2017) · Cell Research · doi:10.1038/cr.2017.15 · Cited by 1,815
The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells
Lin, S., Choe, J., Du, P., Triboulet, R., & Gregory, R. I. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.03.021 · Cited by 1,531
Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP)
Van Nostrand, E. L., Pratt, G. A., Shishkin, A. A., Gelboin-Burkhart, C., Fang, M. Y., Sundararaman, B., Blue, S. M., Nguyen, T. B., Surka, C., Elkins, K., et al. (2016) · Nature Methods · doi:10.1038/nmeth.3810 · Cited by 1,397
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
Bowtell, D. D., Böhm, S., Ahmed, A. A., Aspuria, P.-J., Bast, R. C., Beral, V., Berek, J. S., Birrer, M. J., Blagden, S., Bookman, M. A., et al. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4019 · Cited by 1,367
Vu, L. P., Pickering, B. F., Cheng, Y., Zaccara, S., Nguyen, D., Minuesa, G., Chou, T., Chow, A., Saletore, Y., MacKay, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4416 · Cited by 1,237
m6A RNA Modification Controls Cell Fate Transition in Mammalian Embryonic Stem Cells
Batista, P. J., Molinie, B., Wang, J., Qu, K., Zhang, J., Li, L., Bouley, D. M., Lujan, E., Haddad, B., Daneshvar, K., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.09.019 · Cited by 1,203
Self-citationZhang, C., Samanta, D., Lu, H., Bullen, J. W., Zhang, H., Chen, I., He, X., & Semenza, G. L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602883113 · Cited by 971
Weng, H., Huang, H., Wu, H., Qin, X., Zhao, B. S., Dong, L., Shi, H., Skibbe, J., Shen, C., Hu, C., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2017.11.016 · Cited by 968
Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells
Han, D., Liu, J., Chen, C., Dong, L., Liu, Y., Chang, R., Huang, X., Liu, Y., Wang, J., Dougherty, U., et al. (2019) · Nature · doi:10.1038/s41586-019-0916-x · Cited by 955
Self-citationMa, J., Yang, F., Zhou, C., Liu, F., Yuan, J., Wang, F., Wang, T., Xu, Q., Zhou, W., & Sun, S. (2017) · Hepatology · doi:10.1002/hep.28885 · Cited by 912
Self-citationSmall-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia
Huang, Y., Su, R., Sheng, Y., Dong, L., Dong, Z., Xu, H., Ni, T., Zhang, Z. S., Zhang, T., Li, C., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.03.006 · Cited by 877
Liu, J., Eckert, M. A., Harada, B. T., Liu, S.-M., Lu, Z., Yu, K., Tienda, S. M., Chryplewicz, A., Zhu, A. C., Yang, Y., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0174-4 · Cited by 778
Self-citationmRNA circularization by METTL3–eIF3h enhances translation and promotes oncogenesis
Choe, J., Lin, S., Zhang, W., Liu, Q., Wang, L., Ramirez-Moya, J., Du, P., Kim, W., Tang, S., Sliz, P., et al. (2018) · Nature · doi:10.1038/s41586-018-0538-8 · Cited by 741
m6A-dependent maternal mRNA clearance facilitates zebrafish maternal-to-zygotic transition
Zhao, B. S., Wang, X., Beadell, A. V., Lu, Z., Shi, H., Kuuspalu, A., Ho, R. K., & He, C. (2017) · Nature · doi:10.1038/nature21355 · Cited by 564
m6A facilitates hippocampus-dependent learning and memory through YTHDF1
Shi, H., Zhang, X., Weng, Y.-L., Lu, Z., Liu, Y., Lu, Z., Li, J., Hao, P., Zhang, Y., Zhang, F., et al. (2018) · Nature · doi:10.1038/s41586-018-0666-1 · Cited by 546
Self-citationSong, H., Feng, X., Zhang, H., Luo, Y., Huang, J., Lin, M., Jin, J., Ding, X., Wu, S., Huang, H., et al. (2019) · Autophagy · doi:10.1080/15548627.2019.1586246 · Cited by 517
Self-citationOvarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes
Beaufort, C. M., Helmijr, J. C. A., Piskorz, A. M., Hoogstraat, M., Ruigrok-Ritstier, K., Besselink, N., Murtaza, M., van IJcken, W. F. J., Heine, A. A. J., Smid, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103988 · Cited by 403 · cited 1×
“Albeit A2780 and SKOV3 are most frequently used for ovarian cancer studies, particularly for high-grade serous ovarian cancer, they are probably originated from endometrioid or clear cell ovarian cancer (39).”
BackgroundCheng, M., Sheng, L., Gao, Q., Xiong, Q., Zhang, H., Wu, M., Liang, Y., Zhu, F., Zhang, Y., Zhang, X., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0683-z · Cited by 403
YTH Domain: A Family of N 6-Methyladenosine (m 6 A) Readers
Liao, S., Sun, H., & Xu, C. (2018) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2018.04.002 · Cited by 396
New frontiers in translational control of the cancer genome
Truitt, M. L., & Ruggero, D. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.27 · Cited by 378
YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression
Shi, Y., Fan, S., Wu, M., Zuo, Z., Li, X., Jiang, L., Shen, Q., Xu, P., Zeng, L., Zhou, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12801-6 · Cited by 363
Xu, C., Liu, K., Ahmed, H., Loppnau, P., Schapira, M., & Min, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.680389 · Cited by 320
Erratum: New frontiers in translational control of the cancer genome
Truitt, M. L., & Ruggero, D. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.30 · Cited by 303
RNA m6A methylation participates in regulation of postnatal development of the mouse cerebellum
Ma, C., Chang, M., Lv, H., Zhang, Z.-W., Zhang, W., He, X., Wu, G., Zhao, S., Zhang, Y., Wang, D., et al. (2018) · Genome Biology · doi:10.1186/s13059-018-1435-z · Cited by 252
Oncogene c-Myc promotes epitranscriptome m6A reader YTHDF1 expression in colorectal cancer
Nishizawa, Y., Konno, M., Asai, A., Koseki, J., Kawamoto, K., Miyoshi, N., Takahashi, H., Nishida, N., Haraguchi, N., Sakai, D., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.23554 · Cited by 226
Overexpression of YTHDF1 is associated with poor prognosis in patients with hepatocellular carcinoma
Zhao, X., Chen, Y., Mao, Q., Jiang, X., Jiang, W., Chen, J., Xu, W., Zhong, L., & Sun, X. (2018) · Cancer Biomarkers · doi:10.3233/cbm-170791 · Cited by 222
NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling
Chowdhry, S., Zanca, C., Rajkumar, U., Koga, T., Diao, Y., Raviram, R., Liu, F., Turner, K., Yang, H., Brunk, E., et al. (2019) · Nature · doi:10.1038/s41586-019-1150-2 · Cited by 222
METTL13 Methylation of eEF1A Increases Translational Output to Promote Tumorigenesis
Liu, S., Hausmann, S., Carlson, S. M., Fuentes, M. E., Francis, J. W., Pillai, R., Lofgren, S. M., Hulea, L., Tandoc, K., Lu, J., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.038 · Cited by 210
The m6A reader YTHDF1 regulates axon guidance through translational control of Robo3.1 expression
Zhuang, M., Li, X., Zhu, J., Zhang, J., Niu, F., Liang, F., Chen, M., Li, D., Han, P., & Ji, S.-J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz157 · Cited by 203
Hua, W., Zhao, Y., Jin, X., Yu, D., He, J., Xie, D., & Duan, P. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.09.015 · Cited by 192
Zhang, Y., Wang, X., Zhang, X., Wang, J., Ma, Y., Zhang, L., & Cao, X. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812536116 · Cited by 185
Eukaryotic translation initiation factors in cancer development and progression
Seeboeck, R., Ernst, C., Mehta, A. K., & Haybaeck, J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.06.019 · Cited by 158
The m6A-methylase complex recruits TREX and regulates mRNA export
Lesbirel, S., Viphakone, N., Parker, M. T., Parker, J., Heath, C. G., Sudbery, I. M., & Wilson, S. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-32310-8 · Cited by 142
The role of eIF3 and its individual subunits in cancer
Hershey, J. W. B. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.10.005 · Cited by 112
Tao, X., Chen, J., Jiang, Y., Wei, Y., Chen, Y., Xu, H., Zhu, L., Tang, G., Li, M., Jiang, A., et al. (2017) · BMC Genomics · doi:10.1186/s12864-017-3719-1 · Cited by 111
Hu, C., Wang, Y., Li, A., Zhang, J., Xue, F., & Zhu, L. Y. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27601 · Cited by 107
CSIOVDB: a microarray gene expression database of epithelial ovarian cancer subtype
Tan, T. Z., Yang, H., Ye, J., Low, J. J. H., Choolani, M. A., Tan, D. S. P., Thiery, J. P., & Huang, R. Y. (2015) · Oncotarget · doi:10.18632/oncotarget.5983 · Cited by 89
Yin, J., Shen, J., Dong, Z., Huang, Q., Zhong, M.-Z., Feng, D., Zhou, H.-H., Zhang, J., & Liu, Z. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2591 · Cited by 83
Liu, R.-Y., Dong, Z., Liu, J., Yin, J., Zhou, L., Wu, X., Yang, Y., Mo, W., Huang, W., Khoo, S. K., et al. (2011) · Oncogene · doi:10.1038/onc.2011.189 · Cited by 78
Self-citationeIF3a: A new anticancer drug target in the eIF family
Yin, J., Zhang, J., Zhang, W., Zhou, H.-H., & Liu, Z. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.055 · Cited by 74
Lee, H., Chen, C., Ho, C., Lee, S.-S., Chang, C.-Y., Chen, K., & Jou, Y. (2018) · Oncotarget · doi:10.18632/oncotarget.24149 · Cited by 59
eIF3c: A potential therapeutic target for cancer
Emmanuel, R., Weinstein, S., Landesman‐Milo, D., & Peer, D. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.04.026 · Cited by 41
Li, T., Li, S., Chen, D., Chen, B., Yu, T., Zhao, F., Wang, Q., Yao, M., Huang, S., Chen, Z., et al. (2017) · Cancer Science · doi:10.1111/cas.13209 · Cited by 41
Cited by
The role of m6A modification in the biological functions and diseases
Jiang, X., Liu, B., Nie, Z., Duan, L., Xiong, Q., Jin, Z., Yang, C., & Chen, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00450-x · Cited by 2,335
Targeting the Wnt/β-catenin signaling pathway in cancer
Zhang, Y., & Wang, X. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00990-3 · Cited by 1,431
The potential role of RNA N6-methyladenosine in Cancer progression
Wang, T., Kong, S., Tao, M., & Ju, S. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01204-7 · Cited by 1,013
Roles of METTL3 in cancer: mechanisms and therapeutic targeting
Zeng, C., Huang, W., Li, Y., & Weng, H. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00951-w · Cited by 634
The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities
Nombela, P., Miguel-López, B., & Blanco, S. (2021) · Molecular Cancer · doi:10.1186/s12943-020-01263-w · Cited by 492
Metadata
- Authors
- Liu, T., Wei, Q., Jin, J., Luo, Q., Liu, Y., Yang, Y., Cheng, C., Li, L., Pi, J., Si, Y., Xiao, H., Li, L., Rao, S., Wang, F., Yu, J., Yu, J., Zou, D., & Yi, P.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-01-30
- Volume
- 48
- Issue
- 7
- Pages
- 3816-3831
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W3003715948
- Cited by
- 746
- References
- 53
- FWCI
- 33.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.